Developer docs
API playgroundTry for free, no card

Search company profiles

Michael J. Fox Foundation

Full company profile

uuid0000tgn

Namestring
Michael J. Fox Foundation
Legal namestring
The Michael J. Fox Foundation for Parkinson's Research
Websiteurl
michaeljfox.org
Company typeenum
Private
Founded yearint
2000
Descriptiontext

The Michael J. Fox Foundation for Parkinson's Research (MJFF), founded in 2000 by actor Michael J. Fox and Deborah W. Brooks, is the world's largest nonprofit funder of Parkinson's disease research, with over $2.5 billion deployed across more than two decades. The foundation operates PPMI (the Parkinson's Precision Medicine Initiative, formerly the Parkinson's Progression Markers Initiative), a landmark observational study that has enrolled more than 4,200 in-clinic and 47,000+ online participants across 50+ clinical sites in 12 countries and whose dataset has been downloaded over 50 million times by researchers. It complements PPMI with Fox Trial Finder (a self-service clinical trial matching tool), the Targets to Therapies Initiative, the LRRK2 Investigative Therapeutics Exchange (LITE) program, and the ASAP Collaborative Research Network covering 187 institutions in 24 countries, validating biomarker platforms such as the alpha-synuclein seed amplification assay and supporting a portfolio of 75+ disease-modifying therapies in clinical development.

MJFF funds its programs through a hybrid revenue model that includes individual donations (88 cents of every dollar to research programs), corporate sponsorships (Acadia, AbbVie, Blue Rock Therapeutics), sponsored research support, and grassroots Team Fox fundraising events. It reaches patients, families, and researchers through an omnichannel distribution footprint spanning a 350,000+ provider primary-care partnership (Altura), 23+ city Parkinson's IQ + You events, the annual Unity Walk, an award-winning podcast, monthly webinars, a 135,000+-member Parkinson's Policy Network, and an Altura-enabled community channel serving 150 million+ people. The foundation also drives policy outcomes — including the National Plan to End Parkinson's Act, the Vermont paraquat ban, and the EPA TCE ban — embedding itself in the federal and state regulatory infrastructure for Parkinson's research and care.

Short descriptiontext

The Michael J. Fox Foundation is the world's largest nonprofit funder of Parkinson's disease research, operating the PPMI observational study across 12 countries and deploying over $2.5 billion in research funding to accelerate cures, biomarkers, and clinical trials.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Parkinson's research funding, nonprofit health foundation, clinical trial matching, disease biomarker research, medical research grants
Industry3 codes
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Voluntary Health Organizations813212
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Nonprofit Medical Research Funding
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Individual Donations
TypeOthers
Description

The foundation receives donations from individuals who contribute to fund Parkinson's research. The foundation states that 88 cents of every dollar raised goes to research programs.

michaeljfox.org
2Corporate Sponsorships and Partnerships
TypeOthers
Description

Corporate donors and industry partners provide funding support. Event sponsors include companies like Acadia Pharmaceuticals, Blue Rock Therapeutics, and others for educational events.

michaeljfox.org
3Sponsored Research Support
TypeOthers
Description

Industry sponsors including AbbVie and Acadia Pharmaceuticals provide funding for specific research programs and reports.

michaeljfox.org
4Team Fox Grassroots Fundraising
TypeOthers
Description

Thousands of Team Fox members worldwide organize fundraising events including athletic events, endurance challenges, and DIY fundraisers. HPP's Pacific row raised $43 million for the foundation.

michaeljfox.org
Marketing channels13 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 5 records shown
1PPMI
Description

Parkinson's Precision Medicine Initiative (formerly Parkinson's Progression Markers Initiative) - landmark observational clinical study

michaeljfox.org
+4 more records
Core offering1 text field

The Michael J. Fox Foundation for Parkinson's Research is a 501(c)(3) nonprofit that funds and accelerates Parkinson's disease research worldwide. It deploys donated capital into research grants, operates the landmark PPMI observational study and Fox Trial Finder clinical trial matching platform, produces educational resources and events for patients and families, and coordinates a national policy advocacy network to advance Parkinson's research, treatment, and prevention.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • PPMI enabled validation of the alpha-synuclein seed amplification assay (SAA) for detecting Parkinson's before symptoms appear
+4 more records
Product overview1 text field

The Michael J. Fox Foundation operates primarily as a research funding organization rather than a traditional software product company. Its core digital offerings include the Parkinson's Precision Medicine Initiative (PPMI), a landmark longitudinal research study, and Fox Trial Finder, a clinical trial matching tool. The Foundation also provides educational programs through Parkinson's IQ + You events and publishes resources like the Care Partner Guide. These offerings work together to accelerate Parkinson's research by connecting patients to clinical trials, collecting comprehensive biological data, and educating the community.

Product and service8 records
1Fox Trial Finder
CategoryClinical Trial Matching Platform
Description

Online clinical trial matching tool that connects community members to Parkinson's studies in need of volunteers. Users answer basic questions to receive study matches based on their profile, with AI-powered lay summaries translating technical trial descriptions. Available in multiple languages with no login required.

2Parkinson's Precision Medicine Initiative (PPMI)
CategoryObservational Research Study
Description

Landmark observational study (formerly Parkinson's Progression Markers Initiative) that collects clinical and biological data from participants to drive biology-driven, personalized Parkinson's research. The study includes over 4,200 in-clinic participants across 50 sites in 12 countries and more than 47,000 online participants, with data downloaded over 50 million times by researchers worldwide. Over $800 million invested in building the dataset.

3Parkinson's IQ + You
CategoryEducational Events Program
Description

Free national educational event series that visits cities across the United States to educate and empower people living with Parkinson's disease and their families through interactive panels, research discussions, and a partner expo featuring local and national Parkinson's organizations. Has visited 23+ cities since 2019.

4Facing Parkinson's Together: A Guide for Care Partners
CategoryEducational Resource
Description

Free digital care partner guide providing practical advice, emotional support, and community insights for families dealing with Parkinson's disease. Developed with clinical experts and community contributors.

5ASAP Collaborative Research Network
CategoryGlobal Research Funding Network
Description

Global initiative coordinated by Aligning Science Across Parkinson's in partnership with MJFF that funds 32 international research teams studying Parkinson's disease heterogeneity and advancing precision medicine. Total CRN investment exceeds $550 million, funding 67 teams of nearly 400 investigators across 187 institutions in 24 countries.

6Parkinson's Podcast
CategoryEducational Podcast
Description

Award-winning podcast recognized with Silver and Bronze Signal Awards in 2025, featuring episodes on Parkinson's research, patient experiences, and expert discussions. Distributed through major podcast platforms.

7Third Thursdays Webinar Series
CategoryEducational Webinars
Description

Monthly educational webinar series covering Parkinson's medications, research updates, exercise, genetics, and other topics, with CME credits available.

8Parkinson's Policy Network
CategoryAdvocacy Program
Description

Nationwide grassroots advocacy program with 135,000+ members receiving action alerts, policy updates, and opportunities to engage with federal and state lawmakers around Parkinson's research funding and policy priorities.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-28
Description

MJFF partners with ASAP on the Collaborative Research Network (CRN), which received $261 million in new grant funding. The CRN funds 67 teams of nearly 400 investigators across 187 institutions in 24 countries studying Parkinson's heterogeneity and advancing precision medicine. ASAP's total CRN investment exceeds $550 million. This partnership drives the Global Parkinson's Genetics Program (GP2) and supports PPMI expansion.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to develop sensitive and quantitative biomarker assays for LRRK2 using SISCAPA and TrueSignature targeted proteomics platforms for deployment in clinical trials to provide pharmacodynamic readouts of therapeutic treatment. Supports MJFF's LITE initiative.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership to discover biomarkers and biological pathways related to Parkinson's disease.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

$1.6 million research collaboration to develop single-molecule assay for studying alpha-synuclein using Nautilus' proteomics platform and Weill Cornell Medicine-Qatar's expertise. Aims to detect various forms of alpha-synuclein at detailed resolution to improve early diagnosis.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with Nautilus Biotechnology and MJFF to study the connection between alpha-synuclein protein and Parkinson's disease using single-molecule proteomics.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MJFF awarded $1.5 million grant to Lario Therapeutics to support CaV1.3-linked Parkinson's disease research as part of the company's $2.4 million total funding from MJFF and Wellcome.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

10-year partnership expanding to bring Parkinson's and brain health studies to primary care and community health settings, particularly among historically underrepresented communities. Reaches 150+ million people through 350,000+ healthcare providers.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MJFF supported development of NULISAseq Neuro 220 Panel featuring 15 new Parkinson's disease biomarkers and 12 Tau protein isoform assays for neurological disease research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joined MJFF's LRRK2 Investigative Therapeutics Exchange (LITE) program to evaluate PLA2G15 inhibitor program as disease-modifying approach for Parkinson's, leveraging LITE's biology expertise and biomarker infrastructure.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Digital biomarker technology developed by Roche used in Neuron23's NEULARK Phase 2 trial to monitor motor and non-motor symptoms in Parkinson's patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit sponsor of economic burden report on Parkinson's disease, collaborating on research and advocacy initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit sponsor of economic burden report, partnering on awareness and research efforts.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Nonprofit sponsor of economic burden report, collaborating on advocacy and research for atypical parkinsonisms.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Premier sponsor of Parkinson's IQ + You events, advancing cell-based therapies including Phase III trial of bemdaneprocel for Parkinson's.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic partnership for proteomics research collaboration.

16U.S. Department of Health and Human Services (HHS)
Strategic tierCoreTypeOthers
Description

Federal agency developing and implementing the National Parkinson's Project with guidance from advisory council including MJFF CEO and Patient Council member. Authorized by National Plan to End Parkinson's Act signed into law July 2024.

michaeljfox.org
Strategic tierCoreTypeOthers
Description

Federal research agency collaborating on National Parkinson's Project and receiving advocacy for increased Parkinson's research funding (target: $600 million annually by FY2028).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

National nonprofit also funding Parkinson's research, education, and patient services. Direct peer with overlapping patient programs, co-sponsored economic burden reports, and complementary research funding approach.

TypeDirect peer
Description

National Parkinson's-specific nonprofit providing research funding, patient education, and support services. Direct peer co-sponsoring the $82.2B economic burden report with MJFF and operating similar care partner/patient programs.

TypeDirect peer
Description

Nonprofit focused on atypical parkinsonisms (PSP, CBD, MSA). Direct peer co-sponsoring MJFF's economic burden report and operating in the adjacent neurodegenerative movement disorder space.

TypeDirect peer
Description

Global nonprofit research funder coordinating the Collaborative Research Network with MJFF. Operates as both peer and partner, jointly funding $550M+ across 187 institutions in 24 countries.

5Alzheimer's Association
TypeBroad incumbent
Description

Largest nonprofit funder of Alzheimer's research with a similar research-funding + advocacy + patient-services model. Comparable in scale and structure, but focused on Alzheimer's rather than Parkinson's; serves as the template for large-disease research foundations.

TypeBroad incumbent
Description

Major disease-specific research nonprofit with a comparable model: research funding, advocacy, patient services, biotech grants. Direct structural analog in neurodegenerative disease space; serves a similarly sized patient population.

TypeBroad incumbent
Description

Nonprofit funding research on Alzheimer's, macular degeneration, and glaucoma. Comparable as a smaller disease-focused research grantmaker with a similar portfolio of biotech and academic grants.

TypeEmerging player
Description

Long-running neuroscience research foundation focused on Huntington's disease and related disorders. Comparable in mission style (disease-specific research funding) but smaller scale and narrower disease focus.

TypeOthers
Description

Global charitable foundation co-funding Parkinson's research with MJFF (Lario Therapeutics). Functions as a research grantmaker rather than a disease-specific peer, but is a direct funding partner with similar large-scale biomedical research grantmaking.

10Christopher & Dana Reeve Foundation
TypeOthers
Description

Nonprofit funding spinal cord injury research and paralysis advocacy. Comparable as a celebrity-founded disease-specific research foundation with similar brand-driven fundraising and patient-support models, though in a different therapeutic area.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment115 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Michael J. Fox Foundation

Nonprofit Medical Research Fundingmichaeljfox.org

The Michael J. Fox Foundation is the world's largest nonprofit funder of Parkinson's disease research, operating the PPMI observational study across 12 countries and deploying over $2.5 billion in research funding to accelerate cures, biomarkers, and clinical trials.

What Michael J. Fox Foundation does

The Michael J. Fox Foundation for Parkinson's Research (MJFF), founded in 2000 by actor Michael J. Fox and Deborah W. Brooks, is the world's largest nonprofit funder of Parkinson's disease research, with over $2.5 billion deployed across more than two decades. The foundation operates PPMI (the Parkinson's Precision Medicine Initiative, formerly the Parkinson's Progression Markers Initiative), a landmark observational study that has enrolled more than 4,200 in-clinic and 47,000+ online participants across 50+ clinical sites in 12 countries and whose dataset has been downloaded over 50 million times by researchers. It complements PPMI with Fox Trial Finder (a self-service clinical trial matching tool), the Targets to Therapies Initiative, the LRRK2 Investigative Therapeutics Exchange (LITE) program, and the ASAP Collaborative Research Network covering 187 institutions in 24 countries, validating biomarker platforms such as the alpha-synuclein seed amplification assay and supporting a portfolio of 75+ disease-modifying therapies in clinical development.

MJFF funds its programs through a hybrid revenue model that includes individual donations (88 cents of every dollar to research programs), corporate sponsorships (Acadia, AbbVie, Blue Rock Therapeutics), sponsored research support, and grassroots Team Fox fundraising events. It reaches patients, families, and researchers through an omnichannel distribution footprint spanning a 350,000+ provider primary-care partnership (Altura), 23+ city Parkinson's IQ + You events, the annual Unity Walk, an award-winning podcast, monthly webinars, a 135,000+-member Parkinson's Policy Network, and an Altura-enabled community channel serving 150 million+ people. The foundation also drives policy outcomes — including the National Plan to End Parkinson's Act, the Vermont paraquat ban, and the EPA TCE ban — embedding itself in the federal and state regulatory infrastructure for Parkinson's research and care.

Michael J. Fox Foundation firmographics

Firmographics
Name
Michael J. Fox Foundation
Legal name
The Michael J. Fox Foundation for Parkinson's Research
Website
https://michaeljfox.org
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
501–1,000 employees
Short description
The Michael J. Fox Foundation is the world's largest nonprofit funder of Parkinson's disease research, operating the PPMI observational study across 12 countries and deploying over $2.5 billion in research funding to accelerate cures, biomarkers, and clinical trials.
Ownership category
akta.pro rank

Michael J. Fox Foundation industry classification

Industry
Product category
Nonprofit Medical Research Funding
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Voluntary Health Organizations (813212), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGAKAL
Health & Medical Research Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking
SECONDARYBPAGAKAI
Research & Science Grantmaking Foundations
Business & Public Services/Nonprofit, NGO & Social Services/Philanthropy, Foundations & Grantmaking

Keywords

  • Parkinson's research funding
  • Nonprofit health foundation
  • Clinical trial matching
  • Disease biomarker research
  • Medical research grants

Where Michael J. Fox Foundation is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Michael J. Fox Foundation business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Individual Donations: The foundation receives donations from individuals who contribute to fund Parkinson's research. The foundation states that 88 cents of every dollar raised goes to research programs.
  2. Corporate Sponsorships and Partnerships: Corporate donors and industry partners provide funding support. Event sponsors include companies like Acadia Pharmaceuticals, Blue Rock Therapeutics, and others for educational events.
  3. Sponsored Research Support: Industry sponsors including AbbVie and Acadia Pharmaceuticals provide funding for specific research programs and reports.
  4. Team Fox Grassroots Fundraising: Thousands of Team Fox members worldwide organize fundraising events including athletic events, endurance challenges, and DIY fundraisers. HPP's Pacific row raised $43 million for the foundation.

Go-to-market motion1 record

Distribution channels7 records

Marketing channels13 records

Michael J. Fox Foundation product offering

Product offering

Core offering

The Michael J. Fox Foundation for Parkinson's Research is a 501(c)(3) nonprofit that funds and accelerates Parkinson's disease research worldwide. It deploys donated capital into research grants, operates the landmark PPMI observational study and Fox Trial Finder clinical trial matching platform, produces educational resources and events for patients and families, and coordinates a national policy advocacy network to advance Parkinson's research, treatment, and prevention.

Product overview

The Michael J. Fox Foundation operates primarily as a research funding organization rather than a traditional software product company. Its core digital offerings include the Parkinson's Precision Medicine Initiative (PPMI), a landmark longitudinal research study, and Fox Trial Finder, a clinical trial matching tool. The Foundation also provides educational programs through Parkinson's IQ + You events and publishes resources like the Care Partner Guide. These offerings work together to accelerate Parkinson's research by connecting patients to clinical trials, collecting comprehensive biological data, and educating the community.

Differentiator

Problem solved

Functional benefit

Brands

  • PPMI: Parkinson's Precision Medicine Initiative (formerly Parkinson's Progression Markers Initiative) - landmark observational clinical study
  • Team Fox
  • Fox Trial Finder
  • Parkinson's Policy Network
  • Parkinson's IQ + You

Products and services

  • Fox Trial Finder Online clinical trial matching tool that connects community members to Parkinson's studies in need of volunteers. Users answer basic questions to receive study matches based on their profile, with AI-powered lay summaries translating technical trial descriptions. Available in multiple languages with no login required.
  • Parkinson's Precision Medicine Initiative (PPMI) Landmark observational study (formerly Parkinson's Progression Markers Initiative) that collects clinical and biological data from participants to drive biology-driven, personalized Parkinson's research. The study includes over 4,200 in-clinic participants across 50 sites in 12 countries and more than 47,000 online participants, with data downloaded over 50 million times by researchers worldwide. Over $800 million invested in building the dataset.
  • Parkinson's IQ + You Free national educational event series that visits cities across the United States to educate and empower people living with Parkinson's disease and their families through interactive panels, research discussions, and a partner expo featuring local and national Parkinson's organizations. Has visited 23+ cities since 2019.
  • Facing Parkinson's Together: A Guide for Care Partners Free digital care partner guide providing practical advice, emotional support, and community insights for families dealing with Parkinson's disease. Developed with clinical experts and community contributors.
  • ASAP Collaborative Research Network Global initiative coordinated by Aligning Science Across Parkinson's in partnership with MJFF that funds 32 international research teams studying Parkinson's disease heterogeneity and advancing precision medicine. Total CRN investment exceeds $550 million, funding 67 teams of nearly 400 investigators across 187 institutions in 24 countries.
  • Parkinson's Podcast Award-winning podcast recognized with Silver and Bronze Signal Awards in 2025, featuring episodes on Parkinson's research, patient experiences, and expert discussions. Distributed through major podcast platforms.
  • Third Thursdays Webinar Series Monthly educational webinar series covering Parkinson's medications, research updates, exercise, genetics, and other topics, with CME credits available.
  • Parkinson's Policy Network Nationwide grassroots advocacy program with 135,000+ members receiving action alerts, policy updates, and opportunities to engage with federal and state lawmakers around Parkinson's research funding and policy priorities.

Quantifiable outcome

  • PPMI enabled validation of the alpha-synuclein seed amplification assay (SAA) for detecting Parkinson's before symptoms appear
  • +4 more outcomes

Companies that use Michael J. Fox Foundation

Customer profile

Named customers2 records

Segments6 records

Ideal customer profiles6 records

Michael J. Fox Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Michael J. Fox Foundation partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core and minor.

  • Aligning Science Across Parkinson's (ASAP)coreStrategic or Co-development Partner · 28 April 2026MJFF partners with ASAP on the Collaborative Research Network (CRN), which received $261 million in new grant funding. The CRN funds 67 teams of nearly 400 investigators across 187 institutions in 24 countries studying Parkinson's heterogeneity and advancing precision medicine. ASAP's total CRN investment exceeds $550 million. This partnership drives the Global Parkinson's Genetics Program (GP2) and supports PPMI expansion.
  • Biognosys GroupcoreStrategic or Co-development PartnerPartnership to develop sensitive and quantitative biomarker assays for LRRK2 using SISCAPA and TrueSignature targeted proteomics platforms for deployment in clinical trials to provide pharmacodynamic readouts of therapeutic treatment. Supports MJFF's LITE initiative.
  • MetabolonminorStrategic or Co-development PartnerPartnership to discover biomarkers and biological pathways related to Parkinson's disease.
  • Nautilus BiotechnologycoreStrategic or Co-development Partner$1.6 million research collaboration to develop single-molecule assay for studying alpha-synuclein using Nautilus' proteomics platform and Weill Cornell Medicine-Qatar's expertise. Aims to detect various forms of alpha-synuclein at detailed resolution to improve early diagnosis.
  • Weill Cornell Medicine-QatarcoreStrategic or Co-development PartnerCollaboration with Nautilus Biotechnology and MJFF to study the connection between alpha-synuclein protein and Parkinson's disease using single-molecule proteomics.
  • Lario TherapeuticscoreStrategic or Co-development PartnerMJFF awarded $1.5 million grant to Lario Therapeutics to support CaV1.3-linked Parkinson's disease research as part of the company's $2.4 million total funding from MJFF and Wellcome.
  • AlturacoreStrategic or Co-development Partner10-year partnership expanding to bring Parkinson's and brain health studies to primary care and community health settings, particularly among historically underrepresented communities. Reaches 150+ million people through 350,000+ healthcare providers.
  • Alamar BiosciencescoreStrategic or Co-development PartnerMJFF supported development of NULISAseq Neuro 220 Panel featuring 15 new Parkinson's disease biomarkers and 12 Tau protein isoform assays for neurological disease research.
  • Scenic BiotechcoreStrategic or Co-development PartnerJoined MJFF's LRRK2 Investigative Therapeutics Exchange (LITE) program to evaluate PLA2G15 inhibitor program as disease-modifying approach for Parkinson's, leveraging LITE's biology expertise and biomarker infrastructure.
  • Roche Information SolutionscoreStrategic or Co-development PartnerDigital biomarker technology developed by Roche used in Neuron23's NEULARK Phase 2 trial to monitor motor and non-motor symptoms in Parkinson's patients.
  • Parkinson's FoundationcoreStrategic or Co-development PartnerNonprofit sponsor of economic burden report on Parkinson's disease, collaborating on research and advocacy initiatives.
  • American Parkinson Disease AssociationcoreStrategic or Co-development PartnerNonprofit sponsor of economic burden report, partnering on awareness and research efforts.
  • CurePSPcoreStrategic or Co-development PartnerNonprofit sponsor of economic burden report, collaborating on advocacy and research for atypical parkinsonisms.
  • Blue Rock TherapeuticscoreStrategic or Co-development PartnerPremier sponsor of Parkinson's IQ + You events, advancing cell-based therapies including Phase III trial of bemdaneprocel for Parkinson's.
  • Buck Institute for Research on AgingminorStrategic or Co-development PartnerStrategic partnership for proteomics research collaboration.
  • U.S. Department of Health and Human Services (HHS)coreOthersFederal agency developing and implementing the National Parkinson's Project with guidance from advisory council including MJFF CEO and Patient Council member. Authorized by National Plan to End Parkinson's Act signed into law July 2024.
  • National Institutes of Health (NIH)coreOthersFederal research agency collaborating on National Parkinson's Project and receiving advocacy for increased Parkinson's research funding (target: $600 million annually by FY2028).

Scale indicators15 records

Recent moves6 records

Expansion highlights7 records

Michael J. Fox Foundation competitors and assessment

Company assessment

Direct peers

  • Parkinson's Foundation: National nonprofit also funding Parkinson's research, education, and patient services. Direct peer with overlapping patient programs, co-sponsored economic burden reports, and complementary research funding approach.
  • American Parkinson Disease Association: National Parkinson's-specific nonprofit providing research funding, patient education, and support services. Direct peer co-sponsoring the $82.2B economic burden report with MJFF and operating similar care partner/patient programs.
  • CurePSP: Nonprofit focused on atypical parkinsonisms (PSP, CBD, MSA). Direct peer co-sponsoring MJFF's economic burden report and operating in the adjacent neurodegenerative movement disorder space.
  • Aligning Science Across Parkinson's (ASAP): Global nonprofit research funder coordinating the Collaborative Research Network with MJFF. Operates as both peer and partner, jointly funding $550M+ across 187 institutions in 24 countries.

Broad incumbents

  • Alzheimer's Association: Largest nonprofit funder of Alzheimer's research with a similar research-funding + advocacy + patient-services model. Comparable in scale and structure, but focused on Alzheimer's rather than Parkinson's; serves as the template for large-disease research foundations.
  • ALS Association: Major disease-specific research nonprofit with a comparable model: research funding, advocacy, patient services, biotech grants. Direct structural analog in neurodegenerative disease space; serves a similarly sized patient population.
  • BrightFocus Foundation: Nonprofit funding research on Alzheimer's, macular degeneration, and glaucoma. Comparable as a smaller disease-focused research grantmaker with a similar portfolio of biotech and academic grants.

Emerging players

  • Hereditary Disease Foundation: Long-running neuroscience research foundation focused on Huntington's disease and related disorders. Comparable in mission style (disease-specific research funding) but smaller scale and narrower disease focus.

Others

  • Wellcome Trust: Global charitable foundation co-funding Parkinson's research with MJFF (Lario Therapeutics). Functions as a research grantmaker rather than a disease-specific peer, but is a direct funding partner with similar large-scale biomedical research grantmaking.
  • Christopher & Dana Reeve Foundation: Nonprofit funding spinal cord injury research and paralysis advocacy. Comparable as a celebrity-founded disease-specific research foundation with similar brand-driven fundraising and patient-support models, though in a different therapeutic area.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Michael J. Fox Foundation social profiles

Digital presence

Michael J. Fox Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Michael J. Fox Foundation leadership team

Management profile

Number of profiles

Profiles10 records

Michael J. Fox Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Michael J. Fox Foundation M&A and investment

M&A and investment

M&A

Investments115 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Michael J. Fox Foundation

What does Michael J. Fox Foundation do?

The Michael J. Fox Foundation for Parkinson's Research is a 501(c)(3) nonprofit that funds and accelerates Parkinson's disease research worldwide. It deploys donated capital into research grants, operates the landmark PPMI observational study and Fox Trial Finder clinical trial matching platform, produces educational resources and events for patients and families, and coordinates a national policy advocacy network to advance Parkinson's research, treatment, and prevention.

Is Michael J. Fox Foundation a public or private company?

Michael J. Fox Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Michael J. Fox Foundation founded?

Michael J. Fox Foundation was founded in 2000. It employs 501 to 1,000 people.

Where is Michael J. Fox Foundation based?

Michael J. Fox Foundation is headquartered in New York, United States, in the North America region.

How does Michael J. Fox Foundation make money?

Four revenue lines are on record. Individual Donations are the primary driver. The others are corporate Sponsorships and Partnerships, sponsored Research Support and team Fox Grassroots Fundraising.

Who are Michael J. Fox Foundation's main competitors?

Direct peers on record are Parkinson's Foundation, American Parkinson Disease Association, CurePSP and Aligning Science Across Parkinson's (ASAP). Broad incumbents are Alzheimer's Association, ALS Association and BrightFocus Foundation. Hereditary Disease Foundation is listed as an emerging player. Others are Wellcome Trust and Christopher & Dana Reeve Foundation.

Does Michael J. Fox Foundation have an API?

No public API is recorded for Michael J. Fox Foundation.

What industry is Michael J. Fox Foundation in?

Michael J. Fox Foundation's product category is Nonprofit Medical Research Funding. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooMichael J. Fox and Tracy Pollan's 'very different' relationship revealed after nearly 40 years marriedTracy Pollan spoke at the Michael J. Fox Foundation gala about her 38-year marriage to Michael J. Fox, noting their different tastes but shared love of meals. She highlighted the gala's fundraising for Parkinson's research and her family's support.YahooJohn Oliver Fills in for Tom Papa at Michael J. Fox Foundation Gala After FAA Ground StopJohn Oliver filled in for Tom Papa at the Michael J. Fox Foundation gala in New York after the comedian was grounded by an FAA four-hour nationwide ground stop. The event raised a record $6 million, and John Oliver joked about disappointing the audience. The gala also featured appearances by Stephen Colbert and David Letterman.The Hollywood ReporterJohn Oliver Fills in for Tom Papa at Michael J. Fox Foundation Gala After FAA Ground StopJohn Oliver filled in for Tom Papa at the Michael J. Fox Foundation gala in New York after the FAA ground stop left Papa stuck in Los Angeles. The event raised a record $6 million, and Fox performed with John Mayer and Brad Paisley, vowing to find a cure for Parkinson's.stupidDOPEMichael J. Fox Johnny B. Goode Gala 2026: John Mayer, Brad Paisley and the Record $6 Million NightMichael J. Fox played "Johnny B. Goode" at his Parkinson's foundation gala on November 14, 2026, in New York City, with John Mayer and others. The event raised $6 million, a record for the 26-year-old organization, which has funded nearly $3 billion in research.YahooRebecca Crews Opens Up About Parkinson’s: ‘I’m Not as Concerned About What People Think’Rebecca Crews, diagnosed with Parkinson's in 2015, spoke at the Michael J. Fox Foundation gala in New York City, saying she is no longer concerned about showing symptoms publicly. She recently underwent a second MRI-guided sound wave procedure and remains recovering. Her husband Terry Crews credited Michael J. Fox's example for her openness.PeoplemagMichael J. Fox’s Wife Tracy Pollan Shares Their Favorite Activity to Do Together (Exclusive)Tracy Pollan told PEOPLE that meals together are their favorite activity, during an interview at the Michael J. Fox Foundation gala on Nov. 14. She also said living in the moment is key to staying positive, and the couple has been married for 38 years with four children.YahooMichael J. Fox’s Wife Gets Candid About Their Life Amid His Parkinson’s BattleTracy Pollan spoke at Michael J. Fox's Parkinson's gala, saying they navigate his health day by day and stay present. She praised the foundation's work, which has directed over $3 billion toward research since Fox's 1991 diagnosis.YahooMichael J. Fox’s Wife Gets Candid About Their Life Amid His Parkinson’s BattleTracy Pollan spoke at Michael J. Fox's Parkinson's fundraising gala, discussing how they navigate his health challenges. She emphasized staying present and noted the foundation's $3 billion in research funding. Fox, diagnosed in 1991, continues to support the foundation's mission.PRESSBEEMichael J. Foxs 3 Daughters, Wife Join Actor on Parkinsons Gala Red Carpet ...Middle EastMichael J. Fox attended his Parkinson's gala in New York City with wife Tracy Pollan and their three daughters. The event, the foundation's 26th annual gala, raised funds for research, and Pollan said progress is being seen. Fox also received the Bob Hope Humanitarian Award at the Emmys.YahooMichael J. Fox makes rare appearance with his whole family at annual benefitMichael J. Fox, his wife Tracy Pollan, and their three daughters attended the Michael J. Fox Foundation's annual gala on Saturday. Fox, who has lived with Parkinson's for 35 years, received a standing ovation at the Primetime Emmy Awards earlier this year. The 26th gala featured performances by John Mayer and Tom Papa.